Alle Storys
Folgen
Keine Story von W.O.M. World of Medicine AG mehr verpassen.

W.O.M. World of Medicine AG

EANS-News: W.O.M. World of Medicine AG
Business figures 2009: 3.3% return on sales before taxes, despite decline in sales

Berlin (euro adhoc) -

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
Financial Figures/Balance Sheet
The stock-listed medical device technology
manufacturer W.O.M. WORLD OF MEDICINE AG achieved a 3.3% return on 
sales before taxes for fiscal year 2009 (last year: 14.7%), despite a
decline in sales of 14.0%.
"Against the backdrop of such a precarious and challenging market 
environment as well as targeted investments in more development 
activities, this year's earnings development is indeed satisfactory,"
says Peter P. Wiest, CEO of WORLD OF MEDICINE. "The reluctance to 
invest was especially palpable in the US market. Asia showed the 
greatest level of stability."
Our cash and cash equivalents of EUR7.3 million and our equity ratio 
of 82.6% not only ensure our financial independence, they also offer 
us sufficient leeway to invest in market opportunities arising in the
short-term. Our goal is to achieve sales growth in the low to mid- 
single-digit range in 2010 and 2011, and to elevate the return on 
sales before taxes compared to 2009. An economic recovery, 
particularly in the USA, is the precondition for this.
The complete 2009 Annual Financial Report is available at the 
following link: 
www.world-of-medicine.com/2009/annualfinancialreport/index.htm.
WORLD OF MEDICINE and its technologies are paving the way in 
Minimally Invasive Surgery - or MIS for short. This approach includes
safe and gentle surgical procedures conducted through keyhole or 
puncture incisions, instead of major incisions. The Company is the 
global market leader in a niche of this future market.
end of announcement                               euro adhoc

Further inquiry note:

Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade

Weitere Storys: W.O.M. World of Medicine AG
Weitere Storys: W.O.M. World of Medicine AG